Latest Breaking News On - மாயன் லூபெல் - Page 13 : comparemela.com

By Reuters Staff 3 Min Read JERUSALEM (Reuters) - Israel reported on Monday a decrease in the effectiveness of the Pfizer/BioNTech COVID-19 vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness. FILE PHOTO: A medical worker prepares to administer a vaccination against the coronavirus disease (COVID-19) as Israel continues its national vaccination drive, during a third national COVID lockdown, in Ashdod, Israel January 4, 2021. REUTERS/Amir Cohen/File Photo The decline coincided with the spread of the Delta variant and the end of social distancing restrictions in Israel. Vaccine effectiveness in preventing both infection and symptomatic disease fell to 64% since June 6, the Health Ministry said. At the same time the vaccine was 93% effective in preventing hospitalizations and serious illness from the coronavirus.

Israel generalWilliam macleanEran segalMaayan lubellThomson reuters trust principlesIsrael weizmann institute of scienceHealth ministryWeizmann instituteAri rabinovitchThomson reuters trustவில்லியம் மக்லேந்ஏறன் ஸீகல்மாயன் லூபெல்தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை ப்ரிந்ஸிபல்ஸ்இஸ்ரேல் வெய்ஸ்மேன் நிறுவனம் ஆஃப் அறிவியல்ஆரோக்கியம் அமைச்சகம்